Physician profile
Patrick E Spence
NPI 1922047208
$259.95
in general payments reported to CMS, 2019-2025
8 companies · $42.93 in 2025
The $42.93 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $47.05 · 2024: $170 · 2025: $42.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $59.29 | 2024 | Teg6s Hemostasis System |
| Merck Sharp & Dohme LLC | $50.53 | 2024-2025 | Bridion |
| Viiv Healthcare Company | $43.23 | 2020-2025 | Dovato |
| Gilead Sciences, INC. | $28.67 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $26.73 | 2024 | Zilretta, Iovera, Exparel |
| Covidien LP | $20.18 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.72 | 2024 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Spence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.